Literature DB >> 2115081

Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: a retrospective and prospective study.

G D Harris1, I Fiordalisi, W L Harris, L L Mosovich, L Finberg.   

Abstract

We studied retrospectively, 219 episodes of diabetic ketoacidemia in 119 patients aged 13 months to 30 years, to determine the trend of the concentration of sodium in serum as glucose declined during treatment of uncomplicated episodes and of episodes with complications attributable to brain swelling. Of 20 complication, 13 were minor (headache only) and 7 major (death or near death). The concentration of sodium in serum failed to rise as that of glucose declined in 82 (54%) of 164 uncomplicated episodes and in 18 (95%) of 20 complicated episodes (p less than 0.01). Hence complications were more likely to occur among patients with a failure of the concentration of sodium to rise as glucose declined. Fifty-eight episodes of diabetic ketoacidemia in 40 patients aged 1 1/2 to 20 years were then studied prospectively on a 48-hour treatment plan to provide the volume of deficit evenly, with half the deficit of sodium in the first 42 hours. Sodium concentration in serum rose in 55 (95%) of 58 episodes as that of glucose declined. No patient had a major complication. We conclude that failure of the sodium concentration measured in serum to rise as glucose concentration declines is a marker for excessive administration of free water. An expanded repair period, with repair fluid containing an average of 125 mmol/L Na+ early in therapy, will usually protect against a downward trend in the concentration of sodium in serum and therefore against a rapid decline in effective serum osmolality. This regimen may be protective against near-death episodes and brain herniation during treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115081     DOI: 10.1016/s0022-3476(05)82439-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  28 in total

Review 1.  Non-traumatic coma in children.

Authors:  F J Kirkham
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 2.  Fluid management in diabetic ketoacidosis.

Authors:  C D Inward; T L Chambers
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

3.  Pediatric diabetic ketoacidosis.

Authors:  Sarah Lawrence; Danièle Pacaud; Heather Dean; Margaret Lawson; Denis Daneman
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

Review 4.  Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor?

Authors:  T B Brown
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

Review 5.  Management of diabetic ketoacidosis.

Authors:  Neil H White
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

6.  Fluid management in pediatric patients with DKA and rates of suspected clinical cerebral edema.

Authors:  Daniel S Hsia; Sarah G Tarai; Amir Alimi; Jorge A Coss-Bu; Morey W Haymond
Journal:  Pediatr Diabetes       Date:  2015-03-19       Impact factor: 4.866

Review 7.  Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis.

Authors:  A P C P Carlotti; D Bohn; M L Halperin
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

8.  Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial.

Authors:  Nicole S Glaser; Simona Ghetti; T Charles Casper; J Michael Dean; Nathan Kuppermann
Journal:  Pediatr Diabetes       Date:  2013-03-13       Impact factor: 4.866

9.  Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide.

Authors:  Nicole Glaser; Natalie Yuen; Steven E Anderson; Daniel J Tancredi; Martha E O'Donnell
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

Review 10.  ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

Authors:  D B Dunger; M A Sperling; C L Acerini; D J Bohn; D Daneman; T P A Danne; N S Glaser; R Hanas; R L Hintz; L L Levitsky; M O Savage; R C Tasker; J I Wolfsdorf
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.